A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
Thoroughly revised and updated for its Fourth Edition, this highly acclaimed volume is the most comprehensive reference on hospital epidemiology and infection control. Written by over 150 leading experts, this new edition examines every type of hospital-acquired (nosocomial) infection and addresses every issue relating to surveillance, prevention, and control of these infections in patients and in healthcare workers. This new edition features new or significantly increased coverage of emerging infectious diseases, avian influenza, governmental regulation of infection control and payment practices related to hospital-acquired infections, molecular epidemiology, the increasing prevalence of community-acquired MRSA in healthcare facilities, system-wide infection control provisions for healthcare systems, hospital infection control issues following natural disasters, and antimicrobial stewardship in reducing the development of antimicrobial-resistant organisms.
This title, first published in 1984, focuses primarily on the early Industrial Revolution (c. 1780-1820) in the Stockport district. As the Industrial Revolution in England was the first instance of successful industrialisation, it can still provide many social and economic lessons and also furnish essential evidence for continuing debate over ideology and theory. Therefore, this title will be of interest to students of both history and economics.
The rapidly evolving knowledge base in psychiatry mandates timely updates to the consensus on treating various psychiatric disorders. Fulfilling that mandate is this Third Edition of the state-of- "Treatments of Psychiatric Disorders." With a deliberately pluralistic approach, its 90 chapters include new information on each disorder plus updated accounts of optimal treatments for both children and adults. Although it emphasizes the results of randomized controlled trials when available, this authoritative compendium also features data from uncontrolled studies and accumulated clinical wisdom when there is limited empirical research from which to draw. Further, this definitive text combines these data with highly sophisticated integrative models of treatment to help clinicians select among the available modalities and assemble them into rational conceptual frameworks that maximize the effectiveness of the overall treatment plan. Presenting complex material in a reader-friendly format, this collection of expert opinions-including discussions of sometimes-controversial treatments-helps clinicians meet the daily challenges of treatment planning. With chapters by recognized authorities on every major disorder based on categories from DSM-IV from those affecting infants and children (learning, developmental, anxiety, and mood disorders) to those affecting adolescents and adults (cognitive, substance-related, psychotic, mood and anxiety, dissociative, somatoform, sexual, eating, personality, sleep, and impulse-control disorders), no other reference even comes close to this volume's encyclopedic scope of treatment detail. Quite simply, this reference is the definitive psychiatric treatment text for students, residents, clinicians, and other mental health professionals.
The Advantage Series presents the Feature-Method-Practice approach to teaching computer software applications. Feature describes the step or command; Method shows how to perform it; and Practice asks the students to try it themselves. This enhances critical thinking skills and provides students and instructors with complete application coverage.
The complete and only official rulebook and how-to-play guide to this growing national pastime where owners of Rotisserie League "teams" trade players, develop strategies, keep statistics and lead their teams to the pennant.
The Advantage Series presents the Feature-Method-Practice approach to computer software applications to today's technology and business students. This series implements an efficient and effective learning model, which enhances critical thinking skills and provides students and faculty with complete application coverage.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.